Skip to ContentSkip to Navigation
University of Groningenfounded in 1614  -  top 100 university
About us Practical matters How to find us prof. dr. G.H. (Truuske) de Bock
University Medical Center Groningen

prof. dr. G.H. (Truuske) de Bock

Professor of Oncological Epidemiology

Research interests

The research of Geertruida de Bock is about the early detection of cancer and improvement of outcomes after cancer treatment. To evaluate this in a systematic way, she set up an UMCG’s oncology databiobank OncoLifeS with quality of life as a main outcome. To assess and optimize screening strategies, she works on defining which populations are at risk of cancer and negative outcomes. She does not only consider benefits of screening and treatment, but also the negative effects of over-diagnosis, tumor-induction, false-positive results, and side-effects. Systematic literature reviews, analysis of cohorts and modelling are the most important methods she uses.

Publications

Influence of follow-up, screening age, interval, and compliance on overdiagnosis of ductal carcinoma in situ (DCIS): A modelling study

Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant

Trends in cervical cancer incidence in the Netherlands: A join-point and age–period–cohort analysis (1989–2023)

Advancing Ki67 hotspot detection in breast cancer: a comparative analysis of automated digital image analysis algorithms

Artificial intelligence as an independent reader of risk-dominant lung nodules: influence of CT reconstruction parameters

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

Authors' Reply “Non-Smoking and Non-Drinking Oral Cancer Patients Are at Higher Risk of Second Primary Tumours”

Change in Metabolic Markers and the Risk of Skin Cancer: Results from the Lifelines Cohort Study in the Netherlands

Changes in global quality of life after treatment with immune checkpoint inhibitors in patients receiving different treatment regimens for advanced stage lung cancer in the Netherlands: a 2015-2021 cohort study

Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers

Press/media

Mannen krijgen vaker kankertherapie die de tumor aanpakt dan vrouwen

Mannen krijgen vaker kankertherapie die de tumor aanpakt dan vrouwen

Steeds meer mensen met kanker

Steeds meer mensen met kanker: 'Zien nu effecten van veel roken en zonnen'

UMCG krijgt vier ton subsidie voor verbetering onderzoek naar baarmoederhalskanker.